Imaging Alzheimer's disease pathophysiology with PET

ABSTRACT Alzheimer's disease (AD) has been reconceptualised as a dynamic pathophysiological process characterized by preclinical, mild cognitive impairment (MCI), and dementia stages. Positron emission tomography (PET) associated with various molecular imaging agents reveals numerous aspects of dementia pathophysiology, such as brain amyloidosis, tau accumulation, neuroreceptor changes, metabolism abnormalities and neuroinflammation in dementia patients. In the context of a growing shift toward presymptomatic early diagnosis and disease-modifying interventions, PET molecular imaging agents provide an unprecedented means of quantifying the AD pathophysiological process, monitoring disease progression, ascertaining whether therapies engage their respective brain molecular targets, as well as quantifying pharmacological responses. In the present study, we highlight the most important contributions of PET in describing brain molecular abnormalities in AD.

Bibliographic Details

Main Authors:	Schilling,Lucas Porcello, Zimmer,Eduardo R., Shin,Monica, Leuzy,Antoine, Pascoal,Tharick A., Benedet,Andréa L., Borelli,Wyllians Vendramini, Palmini,André, Gauthier,Serge, Rosa-Neto,Pedro
Format:	Digital revista
Language:	English
Published:	Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2016
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000200079
Tags:	Add Tag No Tags, Be the first to tag this record!